RT Journal Article SR Electronic T1 Prevalence of Perfusion Defects Detected by Stress 99mTechnetium Sestamibi Myocardial Perfusion Single-photon Emission Computed Tomography in Asymptomatic Patients with Breast Cancer JF Anticancer Research JO Anticancer Res FD International Institute of Anticancer Research SP 3689 OP 3694 VO 34 IS 7 A1 BOHUSLAV MELICHAR A1 JIŘÍ DOLEŽAL A1 VLASTISLAV ŠRÁMEK A1 HANA KALÁBOVÁ A1 LENKA KUJOVSKÁ KRČMOVÁ A1 RADOMÍR HYŠPLER A1 HANA ŠTUDENTOVÁ A1 MILAN VOŠMIK A1 MIROSLAV PECKA A1 ADAM SVOBODNÍK A1 LADISLAV PECEN A1 MARTIN DOLEŽEL A1 DAGMAR SOLICHOVÁ YR 2014 UL http://ar.iiarjournals.org/content/34/7/3689.abstract AB Aim: The aim of the present study was to investigate myocardial perfusion in relation to disease history and laboratory parameters of atherosclerosis risk in asymptomatic patients with breast carcinoma. Patients and Methods: One-hundred and eighty-one patients with breast carcinoma were studied. Myocardial perfusion was assessed using single-photon emission computed tomography (SPECT) with 99mtechnetium sestamibi. Results: Perfusion defects were detected in 12 patients (7%). Higher body-mass index, increased concentrations of D-dimers, C-reactive protein, fibrinogen, glucose, triglycerides, and urinary albumin, a history of hypertension and of radiotherapy to the left chest wall were all associated with increased risk of perfusion defects. In a multivariate stepwise selection logistic regression model, body mass index, albuminuria and radiotherapy to the left hemithorax were significantly associated with the presence of perfusion defects. Conclusion: In addition to other factors, treatment history may be associated with the presence of perfusion defects in patients with breast cancer.